Aptinyx Analyst Ratings
Aptinyx Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/16/2022 | — | Truist Securities | Downgrades | Buy → Hold | |
| 08/15/2022 | 425.9% | BMO Capital | $6 → $2 | Maintains | Outperform |
| 08/12/2022 | 425.9% | Piper Sandler | $6 → $2 | Downgrades | Overweight → Neutral |
| 08/05/2022 | 688.85% | SVB Leerink | $4 → $3 | Maintains | Outperform |
| 05/19/2022 | 1477.7% | Piper Sandler | $10 → $6 | Maintains | Overweight |
| 04/21/2022 | 951.8% | SVB Leerink | $10 → $4 | Maintains | Outperform |
| 04/14/2022 | 425.9% | HC Wainwright & Co. | $8 → $2 | Maintains | Buy |
| 04/08/2022 | 1214.75% | Truist Securities | $12 → $5 | Maintains | Buy |
| 04/08/2022 | 1214.75% | Cantor Fitzgerald | $11 → $5 | Maintains | Overweight |
| 12/20/2021 | 2529.5% | SVB Leerink | $12 → $10 | Maintains | Outperform |
| 01/29/2021 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 11/19/2020 | 2003.6% | HC Wainwright & Co. | $7 → $8 | Maintains | Buy |
| 11/13/2020 | 3055.4% | SVB Leerink | $14 → $12 | Maintains | Outperform |
| 10/28/2020 | 3055.4% | Cantor Fitzgerald | $9 → $12 | Maintains | Overweight |
| 10/27/2020 | 2529.5% | Piper Sandler | → $10 | Initiates Coverage On | → Overweight |
| 05/08/2020 | — | William Blair | Initiates Coverage On | → Outperform | |
| 04/29/2020 | 1740.65% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 11/13/2019 | 3318.35% | BMO Capital | $15 → $13 | Maintains | Outperform |
| 09/12/2019 | 1740.65% | Wedbush | → $7 | Initiates Coverage On | → Outperform |
| 08/13/2019 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 03/22/2019 | 3055.4% | Cantor Fitzgerald | $18 → $12 | Maintains | Overweight |
| 01/17/2019 | 2003.6% | JP Morgan | $30 → $8 | Downgrades | Overweight → Neutral |
| 11/15/2018 | 10418.01% | Cantor Fitzgerald | → $40 | Initiates Coverage On | → Overweight |
| 07/16/2018 | 7788.51% | JP Morgan | → $30 | Initiates Coverage On | → Overweight |
| 07/16/2018 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 07/16/2018 | 8314.41% | BMO Capital | → $32 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 08/16/2022 | — | Truist證券 | 評級下調 | 購買→Hold | |
| 08/15/2022 | 425.9% | 蒙特利爾銀行資本 | $6 → $2 | 維護 | 跑贏大盤 |
| 08/12/2022 | 425.9% | 派珀·桑德勒 | $6 → $2 | 評級下調 | 超重→中性 |
| 08/05/2022 | 688.85% | SVB Leerink | $4 → $3 | 維護 | 跑贏大盤 |
| 05/19/2022 | 1477.7% | 派珀·桑德勒 | $10 → $6 | 維護 | 超重 |
| 04/21/2022 | 951.8% | SVB Leerink | $10 → $4 | 維護 | 跑贏大盤 |
| 04/14/2022 | 425.9% | HC Wainwright公司 | $8 → $2 | 維護 | 買 |
| 04/08/2022 | 1214.75% | Truist證券 | $12 → $5 | 維護 | 買 |
| 04/08/2022 | 1214.75% | 康託·菲茨傑拉德 | $11 → $5 | 維護 | 超重 |
| 12/20/2021 | 2529.5% | SVB Leerink | $12 → $10 | 維護 | 跑贏大盤 |
| 01/29/2021 | — | 摩根大通 | 評級下調 | 中性→減持 | |
| 11/19/2020 | 2003.6% | HC Wainwright公司 | $7 → $8 | 維護 | 買 |
| 11/13/2020 | 3055.4% | SVB Leerink | $14 → $12 | 維護 | 跑贏大盤 |
| 10/28/2020 | 3055.4% | 康託·菲茨傑拉德 | $9 → $12 | 維護 | 超重 |
| 10/27/2020 | 2529.5% | 派珀·桑德勒 | → $10 | 開始承保 | →超重 |
| 05/08/2020 | — | 威廉·布萊爾 | 開始承保 | →跑贏大盤 | |
| 04/29/2020 | 1740.65% | HC Wainwright公司 | → $7 | 開始承保 | →購買 |
| 11/13/2019 | 3318.35% | 蒙特利爾銀行資本 | $15 → $13 | 維護 | 跑贏大盤 |
| 09/12/2019 | 1740.65% | 韋德布什 | → $7 | 開始承保 | →跑贏大盤 |
| 08/13/2019 | — | 摩根大通 | 評級下調 | 中性→減持 | |
| 03/22/2019 | 3055.4% | 康託·菲茨傑拉德 | $18 → $12 | 維護 | 超重 |
| 01/17/2019 | 2003.6% | 摩根大通 | $30 → $8 | 評級下調 | 超重→中性 |
| 11/15/2018 | 10418.01% | 康託·菲茨傑拉德 | → $40 | 開始承保 | →超重 |
| 07/16/2018 | 7788.51% | 摩根大通 | → $30 | 開始承保 | →超重 |
| 07/16/2018 | — | 考恩公司 | 開始承保 | →跑贏大盤 | |
| 07/16/2018 | 8314.41% | 蒙特利爾銀行資本 | → $32 | 開始承保 | →跑贏大盤 |
Aptinyx Questions & Answers
Aptinyx問答
The latest price target for Aptinyx (NASDAQ: APTX) was reported by BMO Capital on August 15, 2022. The analyst firm set a price target for $2.00 expecting APTX to rise to within 12 months (a possible 425.90% upside). 9 analyst firms have reported ratings in the last year.
蒙特利爾銀行資本公司於2022年8月15日報道了Aptinyx(納斯達克代碼：APTX)的最新目標價。這家分析公司將目標價定為2美元，預計aptX將在12個月內上漲至(可能上漲425.90%)。去年有9家分析公司公佈了評級。
The latest analyst rating for Aptinyx (NASDAQ: APTX) was provided by BMO Capital, and Aptinyx maintained their outperform rating.
蒙特利爾銀行資本提供了對Aptinyx(納斯達克代碼：APTX)的最新分析師評級，Aptinyx維持了其表現優於大盤的評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aptinyx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aptinyx was filed on August 15, 2022 so you should expect the next rating to be made available sometime around August 15, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閲公共財務報表，與Aptinyx的高管和客户交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Aptinyx的上一次評級是在2022年8月15日提交的，所以你應該預計下一次評級將在2023年8月15日左右的某個時候公佈。
While ratings are subjective and will change, the latest Aptinyx (APTX) rating was a maintained with a price target of $6.00 to $2.00. The current price Aptinyx (APTX) is trading at is $0.38, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Aptinyx(APTX)評級維持不變，目標價在6.00美元至2.00美元之間。Aptinyx目前的交易價格為0.38美元，超出了分析師的預測區間。